Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|July 19, 2023
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cellsMarion Grard, Mohamed Idjellidaine, Atousa Arbabian, et al.Cancer Immunology Research|October 18, 2017
Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor RecurrenceTim Kottke, Laura Evgin, Kevin G Shim, et al.Nature Medicine|November 19, 2013
Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrenceTimothy Kottke, Nicolas Boisgerault, Rosa Maria Diaz, et al.Molecular Therapy. Oncology|January 1, 2026
Development of potent Affitin-based bispecific NK cell engagers for the therapy of MSLN-expressing cancersTina Briolay, Tacien Petithomme, Hermelyne Gravoueille, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2014
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory AgentsShane Zaidi, Miran Blanchard, Kevin Shim, et al.Journal for Immunotherapy of Cancer|June 26, 2020
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesotheliomaThibaut Blondy, Sènan Mickael d'Almeida, Tina Briolay, et al.Oncoimmunology|July 15, 2024
Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironmentCamille Chatelain, Laurine Berland, Marion Grard, et al.Journal of Experimental & Clinical Cancer Research : CR|November 28, 2025
In vitro models to mimic tumor endothelial cell-mediated immune cell reprogramming in lung adenocarcinomaMorgane Krejbich, Emilie Navarro, Judith Fresquet, et al.Molecular Therapy. Oncology|November 4, 2024
Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicityUgo Hirigoyen, Coraly Guilbaud, Morgane Krejbich, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 17, 2020
Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles VirusTiphaine Delaunay, Carole Achard, Nicolas Boisgerault, et al.Pageof 4